Study of Inactivated, Split-Virion Influenza Vaccine Compared With the Reference Vaccine Vaxigrip® in the Elderly

NCT00383526 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3707

Enrollment

INDUSTRY

Sponsor class

Conditions

Orthomyxoviridae Infection
Influenza
Myxovirus Infection

Interventions

BIOLOGICAL: Inactivated, split-virion influenza vaccine
BIOLOGICAL: Inactivated, split-virion influenza vaccine

Sponsor

Sanofi Pasteur, a Sanofi Company